Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Comparing adjuvanted H28 and modified vaccinia virus ankara expressingH28 in a mouse and a non-human primate tuberculosis model
Rolf Billeskov,
Jan Pravsgaard Christensen
, Claus Aagaard, Peter Andersen, Jes Dietrich
24
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Comparing adjuvanted H28 and modified vaccinia virus ankara expressingH28 in a mouse and a non-human primate tuberculosis model'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Post-infection
100%
Nonhuman Primate
100%
Adjuvanted
100%
Interleukin-2
57%
IFN-c
57%
Tumor Necrosis Factor-α
42%
CD4 T Cells
42%
Vaccine Strategy
28%
High Production
28%
CD4+ T Cell Subsets
14%
T Cell Subsets
14%
CD8+ T Cells
14%
Fusion Protein
14%
TB10.4
14%
Recombinant
14%
Immunogenicity
14%
T Cells
14%
Heterologous Prime-boost
14%
Rv2660c
14%
Clinically Significant
14%
Ag85B
14%
Clinical Disease
14%
Antigen-specific
14%
Clinical Pathology
14%
Protective Efficacy
14%
Vaccine Antigen
14%
Immunology and Microbiology
Vaccinia virus
100%
T-Helper Cell
100%
Interleukin 2
100%
Tumor Necrosis Factor
75%
T Cell Subset
50%
Adjuvant
25%
Mycobacterium Bovis BCG
25%
Booster Dose
25%
Immunogenicity
25%
Antigen Specificity
25%
T Cell
25%
Cytotoxic T-Cell
25%